Impact of Day 14 Peripheral Blood Chimerism after Allogeneic Hematopoietic Stem Cell Bone Transplantation on the Treatment Outcome of Non-Malignant Disease.

Conclusion: Although CC is not always necessary after allo-HSCT for non-malignant diseases, our data suggest that day 14 peripheral blood chimerism may predict outcomes in patients with non-malignant diseases who underwent BM/PBSC transplants.
PMID: 30787679 [PubMed - in process]

Source: J Korean Med Sci - February 18, 2019 Category: General Medicine Authors: Choi YB, Lee JW, Sung KW, Koo HH, Kim HJ, Yoo KH Tags: J Korean Med Sci Source Type: research